Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant

被引:32
作者
Montenovo, Martin [1 ]
Rahnemai-Azar, Amir [1 ]
Reyes, Jorge [1 ]
Perkins, James [1 ]
机构
[1] Univ Washington, Dept Surg, Div Transplantat, Seattle, WA 98195 USA
关键词
Diabetes mellitus; Hepatocellular carcinoma; Nonalcoholic steatohepatitis; OUTCOMES; CIRRHOSIS; SURVIVAL;
D O I
10.6002/ect.2016.0277
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: The effect of portal vein thrombosis on the progression of liver disease is controversial, with no consensus on optimal treatment. We aimed to assess how portal vein thrombosis affects wait list outcomes, identify risk factors associated with its development while on a wait list, and assess its effects on patient and graft survival. Materials and Methods: This US-based retrospective cohort study analyzed 134109 adult patients on wait lists for or undergoing primary orthotopic liver transplant between January 2002 and June 2014. Rate of portal vein thrombosis development, time from entry on wait list to transplant, comparisons of wait list drop-off rates between patients with versus those without portal vein thrombosis, risk factors associated with its development while on a wait list, and its effects on patient and graft survival were analyzed. Results: We found that the rate of portal vein thrombosis at listing increased. Patients with the disease at listing were more likely to be removed from wait lists because of being too sick. Portal vein thrombosis at listing was an independent risk factor for being removed from a wait list. Of 63265 patients who underwent primary orthotopic liver transplant, those with the disease were more likely to have higher Model for End-Stage Liver Disease scores and incidence of nonalcoholic steatohepatitis and diabetes mellitus. Portal vein thrombosis had a negative effect on patient and graft survival. Nonalcoholic steatohepatitis, body mass index, diabetes, and hepatocellular carcinoma were identified as risk factors for its development. Conclusions: Portal vein thrombosis represents an increasing management and outcome burden in liver transplant. Having this disease at listing and/or at time of transplant is associated with worse patient and graft survival. Nonalcoholic steatohepatitis and hepato cellular carcinoma are among the biggest risk factors for its development while on a wait list.
引用
收藏
页码:166 / 171
页数:6
相关论文
共 19 条
[1]   Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients [J].
Ayala, Rosa ;
Grande, Silvia ;
Bustelos, Rosalia ;
Ribera, Carmen ;
Garcia-Sesma, Alvaro ;
Jimenez, Carlos ;
Moreno, Enrique ;
Martinez-Lopez, Joaquin .
BMC GASTROENTEROLOGY, 2012, 12
[2]  
Chen HS, 2014, INDIAN J MED RES, V139, P260
[3]   Portal Vein Thrombosis and Liver Transplant Survival Benefit [J].
Englesbe, Michael J. ;
Schaubel, Douglas E. ;
Cai, Shijie ;
Guidinger, Mary K. ;
Merion, Robert M. .
LIVER TRANSPLANTATION, 2010, 16 (08) :999-1005
[4]   Orthotopic Liver Transplantation in Patients With Portal Vein Thrombosis in the Absence of Hepatocellular Carcinoma [J].
Fouzas, I. ;
Paul, A. ;
Becker, C. ;
Vernadakis, S. ;
Treckmann, J. W. ;
Mathe, Z. ;
Gerken, G. ;
Sotiropoulos, G. C. .
TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) :2734-2736
[5]   Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation [J].
Francoz, C ;
Belghiti, J ;
Vilgrain, V ;
Sommacale, D ;
Paradis, V ;
Condat, B ;
Denninger, MH ;
Sauvanet, A ;
Valla, D ;
Durand, F .
GUT, 2005, 54 (05) :691-697
[6]   Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients [J].
Ghabril, Marwan ;
Agarwal, Saurabh ;
Lacerda, Marco ;
Chalasani, Naga ;
Kwo, Paul ;
Tector, A. Joseph .
TRANSPLANTATION, 2016, 100 (01) :126-133
[7]   Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt Using the Transsplenic Approach to Achieve Transplant Candidacy in Patients with Chronic Portal Vein Thrombosis [J].
Habib, Ali ;
Desai, Kush ;
Hickey, Ryan ;
Thornburg, Bartley ;
Vouche, Michael ;
Vogelzang, Robert L. ;
Salem, Riad .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 26 (04) :499-506
[8]   Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis [J].
John, B., V ;
Konjeti, R. ;
Aggarwal, A. ;
Lopez, R. ;
Atreja, A. ;
Miller, C. ;
Zein, N. N. ;
Carey, W. D. .
ANNALS OF HEPATOLOGY, 2013, 12 (06) :952-958
[9]   The friendly incidental portal vein thrombus in liver transplantation [J].
Koh, Peng Soon ;
Chan, See Ching ;
Chok, Kenneth Siu-Ho ;
Sharr, William Wei ;
Wong, Tiffany Cho-Lam ;
Sin, Sui Ling ;
Lo, Chung Mau .
LIVER TRANSPLANTATION, 2015, 21 (07) :944-952
[10]   Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis [J].
Lakhoo, J. ;
Gaba, R. C. .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2016, 97 (11) :1085-1093